Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model

• Published in: European journal of pharmaceutics and biopharmaceutics Vol. 156; pp. 114 - 120
• Main Authors: Bohr, Adam, Tsapis, Nicolas, Foged, Camilla, Andreana, Ilaria, Yang, Mingshi, Fattal, Elias
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-11-2020; Elsevier; Published by Elsevier B.V
• Subjects: Dendriplex; Galenic pharmacology; Life Sciences; Lipopolysaccharide; Lung inflammation; Macrophages; PAMAM dendrimer; Pharmaceutical sciences; siRNA; TNF-α; TNF-α; Lipopolysaccharide; siRNA; Lung inflammation; Dendriplex; Macrophages; PAMAM dendrimer
• ISSN: 0939-6411; 1873-3441
• DOI: 10.1016/j.ejpb.2020.08.009

[Display omitted]
To improve the efficacy of nucleic acid-based therapeutics, e.g., small interfering RNA (siRNA), transfection agents are needed for efficient delivery into cells. Several classes of dendrimers have been found useful as transfection agents for the delivery of siRNA because their surface can readily be functionalized, and the size of the dendriplexes they form with siRNA is within the range of conventional nanomedicine. In this study, commercially available generation 3 poly(amidoamine) (PAMAM) dendrimer was investigated for pulmonary delivery of siRNA directed against tumor necrosis factor (TNF) α for the treatment of acute lung inflammation. Delivery efficiency was assessed in vitro in the RAW264.7 macrophage cell line activated with lipopolysaccharide (LPS), and efficacy was evaluated in vivo in a murine model of LPS-induced lung inflammation upon pre-treatment with TNF-α siRNA. The PAMAM dendrimer-siRNA complexes (dendriplexes) displayed strong siRNA condensation and high cellular uptake in macrophages compared with non-complexed siRNA. Q-PCR analyses showed that the dendriplexes mediated efficient and specific TNF-α silencing in vitro, as compared to non-complexed siRNA and dendriplexes with negative control siRNA. Also in vivo, the PAMAM dendriplexes induced efficacious TNF-α siRNA inhibition, as compared to non-complexed siRNA, upon pulmonary administration to mice with LPS-induced lung inflammation. Hence, these data suggest that PAMAM dendrimers are promising for the local delivery of TNF-α siRNA in the treatment of lung inflammation via pulmonary administration.